Cargando…

Pelacarsen for lowering lipoprotein(a): implications for patients with chronic kidney disease

Chronic kidney disease (CKD) patients are at an increased risk of cardiovascular disease (CVD) and statins may not be protective in advanced CKD. The reasons for the limited efficacy of statins in advanced CKD are unclear, but statins may increase plasma levels of the highly atherogenic molecule lip...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fernandez-Prado, Raul, Perez-Gomez, Maria Vanessa, Ortiz, Alberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Editorial Comments
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7577764/ https://www.ncbi.nlm.nih.gov/pubmed/33123354 http://dx.doi.org/10.1093/ckj/sfaa001

Ejemplares similares

The dirty little secret of urate-lowering therapy: useless to stop chronic kidney disease progression and may increase mortality
por: Gonzalez-Martin, Guillermo, et al.
Publicado: (2020)

Megalin/lipoprotein receptor-related protein 2 autoimmunity and kidney disease
por: Perez-Gomez, Maria V, et al.
Publicado: (2020)

Autosomal dominant polycystic kidney disease: possibly the least silent cause of chronic kidney disease
por: Torra, Roser, et al.
Publicado: (2021)

Who killed Bruce Lee? The hyponatraemia hypothesis
por: Villalvazo, Priscila, et al.
Publicado: (2022)

More on the invisibility of chronic kidney disease… and counting
por: Carriazo, Sol, et al.
Publicado: (2021)

European East–West divide in kidney disease: the need to understand the drivers of chronic kidney disease outcomes
por: Carriazo, Sol, et al.
Publicado: (2020)

RICORS2040: the need for collaborative research in chronic kidney disease
por: Ortiz, Alberto
Publicado: (2021)

Often forgotten, transport modality to dialysis may be life-saving
por: Fernandez-Prado, Raul, et al.
Publicado: (2020)

Probiotics for kidney disease
por: Favero, Chiara, et al.
Publicado: (2022)

EMPA-KIDNEY: expanding the range of kidney protection by SGLT2 inhibitors
por: Fernández-Fernandez, Beatriz, et al.
Publicado: (2023)

Blood pressure targets in patients with chronic kidney disease: MDRD and AASK now confirming SPRINT
por: Sarafidis, Pantelis, et al.
Publicado: (2020)

Hypertensive nephropathy: a major roadblock hindering the advance of precision nephrology
por: Carriazo, Sol, et al.
Publicado: (2020)

Optimizing the timing of nephrology referral for patients with diabetic kidney disease
por: Martínez-Castelao, Alberto, et al.
Publicado: (2020)

Klotho, the elusive kidney-derived anti-ageing factor
por: Sanchez-Niño, Maria Dolores, et al.
Publicado: (2019)

Chronic kidney disease as cardiovascular risk factor in routine clinical practice: a position statement by the Council of the European Renal Association
por: Ortiz, Alberto, et al.
Publicado: (2022)

Aguascalientes: one of the hottest chronic kidney disease (CKD) hotspots in Mexico and a CKD of unknown aetiology mystery to be solved
por: Villalvazo, Priscila, et al.
Publicado: (2021)

Slo-Mo anti-neutrophil cytoplasmic antibody-associated renal vasculitis
por: Avello, Alejandro, et al.
Publicado: (2020)

SGLT2 inhibitors for non-diabetic kidney disease: drugs to treat CKD that also improve glycaemia
por: Fernandez-Fernandez, Beatriz, et al.
Publicado: (2020)

Kidney disease and electrolytes in COVID-19: more than meets the eye
por: Carriazo, Sol, et al.
Publicado: (2020)

Lipoprotein(a): An Enigmatic Sheep in the Lipoprotein Herd
por: Shapiro, Michael D., et al.
Publicado: (2020)

Stopping kidney protection in the elderly following acute kidney injury: think mortality
por: Carriazo, Sol, et al.
Publicado: (2022)

Evidence of chronic kidney injury in patients not meeting KDIGO criteria for chronic kidney disease
por: Alvarez-Llamas, Gloria, et al.
Publicado: (2022)

The unaccomplished mission of reducing mortality in patients on kidney replacement therapy
por: Ortiz, Alberto
Publicado: (2020)

Gain-of-function TLR7 and loss-of-function A20 gene variants identify a novel pathway for Mendelian lupus and lupus nephritis
por: Villalvazo, Priscila, et al.
Publicado: (2022)

Clarifying the concept of chronic kidney disease for non-nephrologists
por: Perez-Gomez, Maria Vanessa, et al.
Publicado: (2019)

Thiazides in chronic kidney disease: “back to the future”
por: de la Espriella, Rafael, et al.
Publicado: (2022)

Coordinating efforts to optimize next-generation kidney replacement therapies: the European Kidney Health Alliance Work Group ‘Breakthrough Innovation’
por: Wieringa, Fokko, et al.
Publicado: (2023)

Benchmarking CKD: incidence of CKD in a European country with low prevalence of CKD and kidney replacement therapy
por: Ortiz, Alberto
Publicado: (2022)

Farewell from the CKJ Editor-in-Chief: key kidney topics from 2014 to 2021
por: Ortiz, Alberto, et al.
Publicado: (2022)

Nicotinamide and acute kidney injury
por: Fontecha-Barriuso, Miguel, et al.
Publicado: (2021)

The last pre-pandemic European Renal Association Registry report: age at start of kidney replacement therapy in Europe
por: Carriazo, Sol, et al.
Publicado: (2021)

Digital health interventions in chronic kidney disease: levelling the playing field?
por: Graham-Brown, Matthew P M, et al.
Publicado: (2022)

Editorial comment on Vitamin K and vascular calcification in chronic kidney disease: An update of current evidence – The role of Vitamin K in managing chronic kidney disease–mineral bone disorder
por: Hou, Yi-Chou, et al.
Publicado: (2022)

COVID-19: implications for immunosuppression in kidney disease and transplantation
por: Kronbichler, Andreas, et al.
Publicado: (2020)

The role of kidney registries in expediting large-scale collection of patient-reported outcome measures for people with chronic kidney disease
por: van der Veer, Sabine N, et al.
Publicado: (2021)

Detecting chronic kidney disease by electrocardiography
por: Kooman, Jeroen P.
Publicado: (2023)

Increase in the global burden of chronic kidney disease: might it be attributable to air pollution?
por: Copur, Sidar, et al.
Publicado: (2022)

Nutrients Turned into Toxins: Microbiota Modulation of Nutrient Properties in Chronic Kidney Disease
por: Fernandez-Prado, Raul, et al.
Publicado: (2017)

Lipoprotein(a): A Taxi for Autotaxin Takes a Toll in Calcific Aortic Valve Disease
por: Towler, Dwight A.
Publicado: (2017)

Lipoprotein (a): A Frustrating Final Frontier in Lipid Management?
por: Libby, Peter
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_8qnnamks178ovs1vn4k1dnthg6